Year: 2023

Map of RegionMap of RegionTORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) — Sintana Energy Inc. (TSX-V: SEI, OTCQB: SEUSF) (“Sintana” or the “Company”) is pleased to provide the following 2023 Review and 2024 Outlook, an update on management and a summary of incentive awards approved at the Company’s annual general meeting. “Building off of our Namibia entry in 2022, 2023 was another year of significant progress for Sintana,” said Robert Bose, President and Director. “The continuing emergence of Namibia’s Orange Basin and the significant progress on both our licenses and on the adjacent blocks, continue to demonstrate the size and scale of the opportunity, the unmatched quality of our portfolio and the timeliness of our entry. Multiple catalysts in the near-term position the Company and its shareholders for success in 2024,” he...

Written Preliminary Comments on the Phase 3 Registration Trial for MAT2203 Move Company Closer to Full Alignment with FDA Matinas to Meet with FDA Early in the First Quarter of 2024 to Finalize Phase 3 Study Design Partnership Discussions Remain Ongoing for MAT2203 BEDMINSTER, N.J., Dec. 21, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform technology, announces receipt of written feedback from U.S. Food and Drug Administration (FDA) on its proposed revised protocol for a Phase 3 study of MAT2203 in patients with invasive aspergillosis with limited or no treatment options. The preliminary written comments move the Company closer to alignment with FDA on the design of...

TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”), announces that pursuant to the Company’s stock option plan, Revival Gold has granted 1,855,000 incentive stock options (the “Options”) to directors, officers, and consultants of the Company as part of its annual compensation plan. The Options are exercisable at a price of $0.50 per share for a period of five years and are subject to vesting provisions. About Revival Gold Inc. Revival Gold is a growth-focused gold exploration and development company. The Company is advancing the Beartrack-Arnett Gold Project located in Idaho, USA. Beartrack-Arnett is the largest past-producing gold mine in Idaho. The Project benefits from extensive existing infrastructure and is the subject of a recent Preliminary Feasibility...

— Transformational Leader Brings Three Decades of Global Experience in Pharmaceutical and Biotechnology Product Development and Commercialization — — Paul J. Hastings Named Chair of the Board — — Dave Stack to Remain in Advisory Role through August 2025 — TAMPA, Fla., Dec. 21, 2023 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that its Board of Directors (the “Board”) has appointed Frank D. Lee as Chief Executive Officer and a member of the Board, effective January 2, 2024. As previously announced in September 2023, David Stack will retire from his roles as Chief Executive Officer and Chairman of the Board, effective January 1, 2024, and will remain with the company...

Leaders in cloud innovation reinforce alliance to provide best-in-class solutions to the financial services industry by extending successful partnership to 2031 Updated commercial terms expected to improve nCino’s subscription gross margins WILMINGTON, N.C., Dec. 21, 2023 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global financial services industry, today announced an expanded partnership with Salesforce to accelerate the delivery of best-in-class cloud solutions to the financial services industry. This builds on nCino and Salesforce’s long-standing collaboration, established in 2011, to empower financial institutions with digital innovations that increase efficiency, transparency, and reduce risks while driving customer growth and loyalty. “Our strategic partnership with Salesforce has enabled...

MONTREAL, Dec. 21, 2023 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce that it has received UL 2723 ECOLOGO® Certification (“ECOLOGO® certification”) for Mineral Exploration Companies. This comprehensive certification is the first certification for mineral exploration companies to consider the identification, management, and application of the best environmental, social, and economic practices. Midland goal is to create long-term value in the mining exploration industry. The Company works in collaboration with all stakeholders to ensure that the principles of transparency and responsibility are respected in all our activities. The certification confirms Midland ability to have better relationships with its stakeholders, contributing to the social acceptability of our projects. Additionally,...

NEW YORK and LEAMINGTON, Ontario, Dec. 21, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its second quarter ended November 30, 2023 on January 9, 2024. Live Audio Webcast Tilray will host a live audio webcast to discuss these results at 8:30 am Eastern Time, which can be accessed on the Investors section of Tilray’s website at www.Tilray.com. A replay will be available and archived on the Company’s website. Retail Investor Q&A Tilray Brands stockholders can submit and upvote questions via the stockholder Q&A platform Say Technologies beginning today and until January 8, 2024. To submit questions ahead of the webcast, please...

THORNTON, Colo., Dec. 21, 2023 (GLOBE NEWSWIRE) — Ascent Solar Technologies, (Nasdaq: ASTI) (“ASTI” or the “Company”), the leading U.S. innovator in the design and manufacture of featherweight, flexible, and durable CIGS thin-film photovoltaic (PV) solutions, announced today that the Company has achieved spaceflight heritage for its space PV array products manifested on the Momentus Vigoride-6 mission. The assembly flown was composed of ASTI’s Plug & Fly™ solar panels, consisting of thin-film modules that were integrated into Momentus’s Tape Spring Solar Array (TASSA), which recently completed initial in-space testing. Beyond establishment of NASA Technology Readiness Level 9 (TRL9) for the Company’s products, this achievement also validates Ascent’s CIGS material, manufacturing, integration, and quality processes,...

TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval in Turkey from the Kocaeli University Clinical Research Ethics Committee to proceed with a Phase II trial for LSALT peptide, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). LSALT peptide is the Company’s lead drug candidate for preventing and treating inflammation injury in the kidneys, lungs and liver. The ethics committee approval of the trial will be followed by a final regulatory review conducted by the Turkish Ministry of Health (MoH), expected to be completed by mid-January. Once the trial is approved by the MoH, activation of clinical sites in Turkey will take place and patient enrollment can begin in February. Quote...